Roger A. Goldberg, MD, MBA; David R.P. Almeida, MD, PhD, MBA; Jennifer I. Lim, MD, FARVO

Community Practice Connections™: Novel Therapies for Neovascular Retinal Disease – Expert Analysis of New Key Data

Mark Pennesi, MD, PhD, FARVO; Laxmi V. Devisetty, MD; M. Dominik Fischer, MD, DPhil, FEBO, MRCOphth; Ramiro Maldonado, MD

 Latest Advances in X-Linked Retinitis Pigmentosa: Optimizing Diagnosis and Developments in Gene Therapy

Zev A. Wainberg, MD; Tanios Bekaii-Saab, MD, FACP; Eileen O’Reilly, MD; Shubham Pant, MD, MBBS

Medical Crossfire®: Starting at the Front Line in Metastatic Pancreatic Cancer – As New Options Emerge, How Do You Select and Sequence?

Sunir Garg, MD; Diana V. Do, MD; Rahul N. Khurana, MD; Christina Y. Weng, MD, MBA

Cases & Conversations™: Real World Review of Treat and Extend Strategies for Neovascular Retinal Disease

Inder Paul Singh, MD; Deborah Ristvedt, DO; Arsham Sheybani, MD; Melissa Tawa, OD, FAAO

Community Practice Connections™: Innovations and Interdisciplinary Approaches in Glaucoma Management—Expanding the Treatment Arsenal (CME Track)

Community Practice Connections™: Innovations and Interdisciplinary Approaches in Glaucoma Management—Expanding the Treatment Arsenal (COPE Track)

Community Oncology Connections™: Community Oncologists’ Role in Selecting Optimal Oral SERD Treatment for HR+/HER2– Breast Cancer | Kentucky

Rebecca Heist, MD, MPH; Alex A. Adjei, MD, PhD, FACP; Sandip Patel, MD, FASCO; Jeremy Segal, MD, PhD

Medical Crossfire®: Expert Perspectives on Targeting c-Met Overexpression and 𝘔𝘌𝘛 Genomic Alterations in NSCLC – Unveiling the Complexities of 𝘔𝘌𝘛 Dysregulation

Balazs Halmos, MD, MS; Enriqueta Felip, MD, PhD; Julia Rotow, MD

Tumor Board: Expert Insights on Managing Classical 𝘌𝘎𝘍𝘙 Mutations, 𝘌𝘎𝘍𝘙 Exon 20 Insertions, and Atypical 𝘌𝘎𝘍𝘙 Mutations in Metastatic NSCLC

C. Ola Landgren, MD, PhD; Mohamad Mohty, MD, PhD; Surbhi Sidana, MD

Medical Crossfire®: Harnessing the Power of Modern Therapies in Newly Diagnosed Multiple Myeloma

Cases and Conversations™: Sorting Through the Expanding Treatment Options for Patients with Relapsed/Refractory Multiple Myeloma

Aditya Bardia, MD, MPH, FASCO; Joyce O’Shaughnessy, MD; Hope S. Rugo, MD; Paolo Tarantino, MD

Breast Cancer Tumor Board®: Advancing Care in Metastatic Breast Cancer—The Evolving Role of Antibody-Drug Conjugates

Eileen M. O’Reilly, MD; E. Gabriela Chiorean, MD, FASCO; Michael J. Pishvaian, MD, PhD; Brian Wolpin, MD, MPH

Evolving Treatment Strategies in Pancreatic Cancer: Current Standards, Emerging Targets, and the Role of Molecular Testing

Gail J. Roboz, MD; Hagop Kantarjian, MD; Catherine Lai, MD, MPH; Amer Zeidan, MBBS, MHS

Cases & Conversations™: Transforming AML Care—Precision Strategies, Evolving Therapies, and Clinical Insights

Jonathan W. Goldman, MD; Percy Lee, MD, FASTRO; Erminia Massarelli, MD, PhD, MS; Misty D. Shields, MD, PhD

PER Tumor Board®: Applying Recent Advances to Transform the Treatment Paradigm in SCLC—Expert Perspectives on New Approvals and Emerging Strategies

Benjamin P. Levy, MD; Ticiana Leal, MD; Aaron Lisberg, MD; Christine M. Lovly, MD, PhD, FASCO

Medical Crossfire®: The Precision Path for HER2 and TROP2-Targeted Treatments in Non–Small Cell Lung Cancer

Vinay K. Puduvalli, MD; Manmeet Ahluwalia, MD, MBA; Stephen J. Bagley, MD, MSCE; Angela Waanders, MD, MPH, MS

Medical Crossfire®: Precision Medicine in Glioma Treatment—Integration of Molecular Profiling to Inform Targeted Therapies

Jacob Sands, MD; Jennifer Carlisle, MD; Hossein Borghaei, DO, MS

Medical Crossfire®: DLL3-Driven Innovations in Small Cell Lung Cancer – How Do Experts Apply Pivotal Advances to Practice?

Rachel N. Grisham, MD; Ramez N. Eskander, MD; Oladapo Yeku, MD, PhD

Show Me the Data™ New Frontiers in the Treatment of Ovarian Cancer

William J. Gradishar, MD, FASCO, FACP; Laura Huppert, MD; Yuan Yuan, MD, PhD

Medical Crossfire®: Integrating Next-Generation Endocrine Targeting Therapies to Improve Outcomes for Patients With HR+/HER2- Breast Cancer

John H. Strickler, MD; Stacey A. Cohen, MD; Aparna Parikh, MD; Kanwal P.S. Raghav, MBBS, MD

GI Tumor Board—Applying Recent Advances in Biomarker Testing and Treatment in Metastatic Colorectal Cancer

Rami Komrokji, MD; Gabriela Hobbs, MD; John Mascarenhas, MD; Naveen Pemmaraju, MD

Medical Crossfire®: Improving Patient Outcomes in Myeloproliferative Neoplasms With Novel Therapeutic Approaches

Joseph Mikhael, MD, MEd, FRCPC, FACP; Amrita Krishnan, MD, FACP; Shaji Kumar, MD; Ashley Rosko, MD

Medical Crossfire®: Risk-Adapted Management of Multiple Myeloma—How Do the Experts Do It?

Melissa Johnson, MD; Dara Aisner, MD, PhD; David R. Gandara, MD; Balazs Halmos, MD, MS

Top 10 Oncogenic Drivers in NSCLC for 2024: Where Are We and Where Are We Going?

Karen M. Winkfield, MD, PhD; Narjust Florez, MD, FASCO; Gilberto de Lima Lopes Junior, MD, MBA, FASCO; Coral Olazagasti, MD; Vonetta M. Williams, MD, PhD

 Fighting Disparities and Saving Lives: An Exploration of Challenges and Solutions in Cancer Care

Peter Voorhees, MD; Noopur Raje, MD; Saad Z. Usmani, MD, MBA, FACP, FASCO

Broadening Horizons in Newly Diagnosed Multiple Myeloma—Exploring New Combination Approaches and Their Impact

Ticiana Leal, MD; Jennifer W. Carlisle, MD; Nisha Mohindra, MD; Martin Wermke, MD

DLL3 as a Therapeutic Target in SCLC and Beyond: Rationale, Recent Data and Potential for Transformations in Care with T-Cell Engagers

Hanny Al-Samkari, MD; Michele P. Lambert, MD, MSTR; Joseph Shatzel, MD, MCR

Welcome to the Rhode Island Oncology Society

WELCOME

UPCOMING MEETINGS

ONCOLOGY NEWS

MEMBER BENEFIT